Whether they study helmets on the football field or hemophilia in a lab, our scientists at Children’s Hospital of Philadelphia Research Institute are always on the cutting-edge of their respective fields, as the latest roundup of research news shows. This week, read about what to expect at next week’s Pediatric Academic Societies Meeting, discover how a CHOP engineer is helping to make the NFL safer, and learn about new results from our Center for Fetal Research about treating lung diseases in utero.
Tag Archive: Center for Fetal Diagnosis and Treatment
In a first-of-its kind study, scientists performed prenatal gene editing in animals to prevent a lethal metabolic disorder and effectively open the door for similarly treating congenital diseases in humans before birth. Using gene editing technology, the team successfully targeted a gene that regulates cholesterol levels to lower cholesterol and, additionally, turned off the effects of a mutation that causes a lethal liver disease called hereditary tyrosinemia type 1 (HT1) in mice.
Our breakthrough research at Children’s Hospital of Philadelphia Research Institute made headlines in both popular science media outlets and prominent scientific journals alike, from advances in detecting sepsis, to pioneering work in prenatal gene editing, to the future of genomic medicine. Read on to learn more about how our scientists stay at the cutting-edge of their fields by approaching pediatric medicine inventively, whether it’s by developing the most effective alerts in emergency medicine, modernizing genetic testing models to keep up with an accelerating pace of discovery, and beyond.
The new year brings brand-new opportunities to advance pediatric research at Children’s Hospital of Philadelphia Research Institute, and if the first two weeks of 2018 are any indication, our investigators are off to a remarkable start. With January marking National Birth Defects Prevention Month, the Center for Fetal Diagnosis and Treatment at CHOP embarked on a campaign to raise awareness for birth defect treatments and research. Meanwhile, our friends at PolicyLab released an exciting video communicating their passionate mission to improve the well-being of children and families. This week, we also cover new pathways to discovery for conditions both rare and common, from hyperinsulinism to alopecia. If (like us), your new year’s resolution is to stay up to date with the latest CHOP research headlines, you’re in the right place!
It has been a whirlwind week for most Americans, so if you need to break away from political news to catch up with your science news, you’ve come to the right place.
This week we’re all about getting smart in our highlights of research news from The Children’s Hospital of Philadelphia. Getting smart in the approach to tackling childhood cancer means identifying strategies that will make a decade’s progress in half the time.
Hats off to N. Scott Adzick, MD, surgeon-in-chief and the founder and director of the Center for Fetal Diagnosis and Treatment at The Children’s Hospital of Philadelphia, on receiving Pennsylvania Bio’s Patient Impact Award at the organization’s annual dinner March 11.
Fetal spina bifida surgery to repair myelomeningocele is a remarkable and intricate procedure performed before birth. If untreated, spinal cord damage from amniotic fluid exposure is progressive during gestation.
The Center for Fetal Diagnosis and Treatment at CHOP serves more than 150 families with complicated multiples pregnancies each year and performs more than 50 fetoscopic laser surgeries annually, one of the highest volumes of prenatal laser surgeries in the nation.